TR200001040T2 - Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı - Google Patents

Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı

Info

Publication number
TR200001040T2
TR200001040T2 TR2000/01040T TR200001040T TR200001040T2 TR 200001040 T2 TR200001040 T2 TR 200001040T2 TR 2000/01040 T TR2000/01040 T TR 2000/01040T TR 200001040 T TR200001040 T TR 200001040T TR 200001040 T2 TR200001040 T2 TR 200001040T2
Authority
TR
Turkey
Prior art keywords
compounds
new use
itch effect
itch
effect
Prior art date
Application number
TR2000/01040T
Other languages
English (en)
Inventor
E. Griswold Don
Benjamin Christensen Siegfried Iv
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200001040T2 publication Critical patent/TR200001040T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Kasinti olusturan hastaliklarin veya rahatsizliklarin önleme veya tedavisinde kullanilan 8-baska maddelerle degistirilmis iksantinlerin türevleri
TR2000/01040T 1997-10-17 1998-10-16 Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı TR200001040T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17

Publications (1)

Publication Number Publication Date
TR200001040T2 true TR200001040T2 (tr) 2001-01-22

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01040T TR200001040T2 (tr) 1997-10-17 1998-10-16 Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı

Country Status (18)

Country Link
EP (1) EP1030666A4 (tr)
JP (1) JP2001520196A (tr)
KR (1) KR20010031149A (tr)
CN (1) CN1306426A (tr)
AR (1) AR015966A1 (tr)
AU (1) AU740875B2 (tr)
BR (1) BR9814080A (tr)
CA (1) CA2306985A1 (tr)
CO (1) CO4810374A1 (tr)
CZ (1) CZ20001376A3 (tr)
HU (1) HUP0003792A3 (tr)
IL (1) IL135581A0 (tr)
NO (1) NO20001847L (tr)
NZ (1) NZ503551A (tr)
PL (1) PL341062A1 (tr)
TR (1) TR200001040T2 (tr)
WO (1) WO1999020280A1 (tr)
ZA (1) ZA989450B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
KR20030070150A (ko) 2001-01-31 2003-08-27 화이자 프로덕츠 인크. Ｐｄｅ4 이소자임 억제제로서 유용한 에테르 유도체
EP1355907A1 (en) 2001-01-31 2003-10-29 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
WO2005007161A1 (ja) * 2003-07-17 2005-01-27 Santen Pharmaceutical Co., Ltd. ピペリジン誘導体を有効成分とする掻痒治療剤
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
AU2005212816C1 (en) * 2004-02-14 2010-03-04 Glaxosmithkline Llc Novel compounds
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
PT1912991E (pt) 2005-08-10 2011-01-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de hm74a
CN101389612B (zh) * 2006-02-21 2011-09-21 卫材R&D管理有限公司 喹唑啉衍生物
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
WO2009025239A1 (ja) 2007-08-17 2009-02-26 Eisai R & D Management Co., Ltd. 新規外用剤
CN102336717B (zh) 2007-08-17 2013-09-18 卫材R&D管理有限公司 喹唑啉衍生物
JP5985475B2 (ja) * 2011-06-28 2016-09-06 田辺三菱製薬株式会社 新規医薬組成物
SI3251675T1 (sl) 2015-01-30 2021-08-31 Shanton Pharma Pte. Ltd. Preprečevanje ali zdravljenje sečnokislinske ali protinske bolezni

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (es) * 1990-12-21 2000-10-16 Beecham Group Plc Derivados de xantina.
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
EP0912568B1 (en) * 1996-05-15 2002-11-20 ALTANA Pharma AG imidazopyridines
JP2001514640A (ja) * 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
BR9810409A (pt) * 1997-03-18 2000-08-22 Basf Ag Métodos e composições para a modulação de responsividade a corticosteróides
ATE232864T1 (de) * 1997-06-03 2003-03-15 Altana Pharma Ag Benzonaphthyridine

Also Published As

Publication number Publication date
WO1999020280A1 (en) 1999-04-29
JP2001520196A (ja) 2001-10-30
PL341062A1 (en) 2001-03-26
NO20001847D0 (no) 2000-04-10
NZ503551A (en) 2002-05-31
IL135581A0 (en) 2001-05-20
CZ20001376A3 (cs) 2002-06-12
AU740875B2 (en) 2001-11-15
AU1093899A (en) 1999-05-10
CO4810374A1 (es) 1999-06-30
KR20010031149A (ko) 2001-04-16
HUP0003792A3 (en) 2001-12-28
CN1306426A (zh) 2001-08-01
NO20001847L (no) 2000-04-10
HUP0003792A2 (hu) 2001-10-28
ZA989450B (en) 1999-04-19
CA2306985A1 (en) 1999-04-29
EP1030666A4 (en) 2002-10-16
BR9814080A (pt) 2000-09-26
AR015966A1 (es) 2001-05-30
EP1030666A1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
CY1105144T1 (el) Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες
ES2060310T3 (es) Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
TR199800815A2 (tr) Sülfonilaminokarbonasitler.
ATE231872T1 (de) Thiazolopyrimidinderivate
ES2192839T3 (es) Timosina beta 4 oxidada.
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
TR199800270T1 (tr) Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.
HRP20090336T1 (en) Antitumor combinations containing vegf - trap and 5fu or one of its derivatives
TR200101722T2 (tr) Serivastatin ve fibratların birleşimi.
TR199802351T2 (tr) Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi.
TR199900505T2 (tr)
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
TR199801798T2 (tr) Otizm tedavisi.
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
NO20005548L (no) Mykobakterieinhibitorer
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.